Assessing motivation for physicians to prevent antimicrobial resistance in hospitalized children using the Health Belief Model as a framework.
BACKGROUND
Antimicrobial resistance (AR) is a threat to hospitalized children, and more information is needed to motivate physicians to adopt evidence-based practices such as those in the Centers for Disease Control and Prevention's (CDC) Campaign to Prevent Antimicrobial Resistance.


METHODS
The framework of the Health Belief Model (HBM) was used to assess personal perceptions and cues to action related to the prevention of AR in 3 national focus groups in August 2003.


RESULTS
Twenty-five physicians who treat hospitalized children participated; all reported that they had cared for a patient with an antimicrobial-resistant organism. Physicians perceived that AR was more of a problem nationally (92%) than in their institution (76%) or practice (60%) and reported that issues such as nursing shortage, cost of health care, and lack of specialty services presented more of a challenge to the care of hospitalized children than AR. Reported preferences of cues to action included journal articles (80%), infectious disease experts (76%), and colleagues (52%).


CONCLUSIONS
The HBM provides insight into physicians' perceptions about AR and preferred cues to action, which yield valuable information concerning the modes, methods, and messengers to intervene on problems such as antimicrobial resistance in hospitalized children.
Brinsley
Kristin J
KJ
Division of Healthcare Quality Promotion, National Center for Infectious Diseases, Centers for Disease Control and Prevention, United States Department of Health and Human Services, Atlanta, GA 30333, USA. aof4@cdc.gov
Sinkowitz-Cochran
Ronda L
RL
Cardo
Denise M
DM
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001291:Attitude of Health Personnel; D002648:Child; D024881:Drug Resistance, Bacterial; D017144:Focus Groups; D006801:Humans; D017053:Infection Control; D008960:Models, Psychological; D009042:Motivation; D010820:Physicians; D014481:United States
D000900:Anti-Bacterial Agents